Page last updated: 2024-08-22

molybdenum and Choroid Neovascularization

molybdenum has been researched along with Choroid Neovascularization in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Brewer, GJ; Vine, AK	1

Trials

1 trial(s) available for molybdenum and Choroid Neovascularization

Article	Year
Tetrathiomolybdate as an antiangiogenesis therapy for subfoveal choroidal neovascularization secondary to age-related macular degeneration. Transactions of the American Ophthalmological Society, 2002, Volume: 100 Topics: Administration, Oral; Aged; Angiogenesis Inhibitors; Ceruloplasmin; Choroidal Neovascularization; Disease Progression; Female; Follow-Up Studies; Fovea Centralis; Humans; Macular Degeneration; Male; Molybdenum; Safety; Treatment Outcome; Visual Acuity	2002

Article

Year

Tetrathiomolybdate as an antiangiogenesis therapy for subfoveal choroidal neovascularization secondary to age-related macular degeneration.

Transactions of the American Ophthalmological Society, 2002, Volume: 100

Topics: Administration, Oral; Aged; Angiogenesis Inhibitors; Ceruloplasmin; Choroidal Neovascularization; Disease Progression; Female; Follow-Up Studies; Fovea Centralis; Humans; Macular Degeneration; Male; Molybdenum; Safety; Treatment Outcome; Visual Acuity

2002